Neogen EPS misses by $0.01, beats on revenue
- BySeeking Alpha-
Neogen (NEOG): FQ1 GAAP EPS of $0.16 misses by $0.01.Revenue of $128.31M (+17.4% Y/Y) beats by $7.11M.Press Release
Symbol | Exchange | Currency |
|---|
Neogen (NEOG): FQ1 GAAP EPS of $0.16 misses by $0.01.Revenue of $128.31M (+17.4% Y/Y) beats by $7.11M.Press Release
Neogen Corporation (NASDAQ: NEOG) has acquired CAPInnoVet, Inc, an Atlanta-based companion animal health company. Deal terms were not disclosed.CAPInnoVet, founded in 2014,...
Neogen Corp. received an administrative subpoena from the Treasury's Office of Foreign Assets Control over the company's dealings with parties in Iran.
Neogen Corporation’s (NASDAQ:NEOG) third-quarter fiscal 2020 earnings per share (EPS) of 23 cents lagged the Zacks Consensus Estimate of 27 cents by 14.8%. The...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
| Technical Indicators | Strong Buy | Buy | Strong Buy | Neutral | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 146.78 | 147.08 | 145.65 | +0.93 | +0.64% | 50.43M | NASDAQ | |||
| 2,827.80 | 2,833.80 | 2,810.10 | +22.2 | +0.79% | 758.94K | NASDAQ | |||
| 345.93 | 349.66 | 343.00 | +2.72 | +0.79% | 18.47M | NASDAQ | |||
| 225.05 | 225.25 | 219.00 | +5.64 | +2.57% | 20.64M | NASDAQ | |||
| 44.33 | 44.71 | 44.19 | +0.38 | +0.85% | 13.19M | NYSE | |||
| 283.76 | 289.01 | 282.56 | -4.72 | -1.64% | 379.54K | NYSE | |||
| 150.47 | 152.68 | 149.61 | -1.42 | -0.93% | 18.85M | NYSE | |||
| 159.34 | 160.26 | 158.28 | +1.90 | +1.21% | 6.80M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 18.23 | 18.37 | 18.09 | -0.21 | -1.17% | 16.74M | NYSE | |||
| 278.78 | 279.19 | 266.40 | +19.61 | +7.57% | 12.67M | NYSE | |||
| 40.32 | 41.85 | 39.93 | +0.24 | +0.60% | 36.28M | NYSE | |||
| 11.96 | 12.18 | 11.86 | -0.33 | -2.69% | 3.33M | NYSE | |||
| 452.99 | 455.49 | 451.10 | +0.66 | +0.15% | 1.26M | NASDAQ | |||
| 5.34 | 5.43 | 5.30 | -0.110 | -2.02% | 11.38M | NYSE |
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.